Skip to content

Treatment interruption results in lipid reduction; IL-2 has no effect on lipids

Treatment interruption 'safe' in those with lowest-ever CD4 counts above 250 cells/mm3

Pilot study finds weekend breaks from HAART may be possible on NNRTIs

CD4-guided treatment interruptions safe and cost-effective, Thai study shows

Short-cycle intermittent HAART maintains undetectable viral load, but does not increase CD4 counts

Stopping nevirapine five days prior to nucleosides may avoid resistance

Differences found between patients stopping HAART for medical or lifestyle reasons

Treatment interruptions in salvage therapy: latest